Dr. Shafiq Rab and John Kravitz, executives at Tufts Medicine and Geisinger, said AWS will offer them better connectivity speed and business continuity than other cloud vendors.
In the next five years, healthcare and life sciences organizations will be navigating unique, disruptive forces presented by a digital-first world that will shape many aspects of the industry landscape from value-based care to prescription digital therapeutics. A report from IDC Research, a premier global market research company, offers some predictions on how organizations can navigate the winds of change impacting what technologies to adopt, capabilities to advance, and partnerships to pursue.
The recent IDC FutureScape: Worldwide Healthcare Industry 2022 Predictions moving healthcare and life sciences organizations forward in a digital-first world
The role innovative and disruptive technologies will play in helping healthcare become more connected and personalized
Top business and IT considerations for organizations as the industry continues to digitally transform
Not able to attend? We recommend you still register and you will receive an email with how to access the recording of the event.
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities, plus showcase how your company is changing the future of digital health.
Regeneron Pharmaceuticals has big plans for cancer immunotherapy Libtayo and it believes it can better execute on them if it has full control of the drug, currently partnered with Sanofi. Regeneron struck a deal to pay Sanofi $900 million, plus another $200 million in milestones, to secure full global rights to the asset.
Ascension Health notified the employees that there was too great of a risk for them to return to work without being vaccinated, but the majority of those who were laid off were asked to return to work shortly after
At the INVEST Digital Health conference, scheduled for Wednesday, September 28, in Dallas and presented in collaboration with Health Wildcatters, healthcare experts will address a wide range of topics in the context of how employers are addressing healthcare needs of their workforce.
Providers would be wise to improve their EMR system response time and reliability, as these two measures critically influence clinician satisfaction. These improvements are acutely needed amid healthcare's workforce shortage — burnout and EMR dissatisfaction are key factors associated with clinicians' likelihood to resign.
Roche's deep oncology pipeline is adding a drug candidate from Repare Therapeutics that works by interfering with a DNA repair mechanism of cancer cells. Repare receives $125 million up front and it retains the right to share in the development and commercialization of the drug, camonsertib.
In this podcast Mike Alkire talks about the importance of health systems achieving scale such that they are in a better position vis-a-vis payers who are typically much larger.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments